nach oben

Diabetologia

Erschienen in:

01.03.2005 | Article

High glucose and hydrogen peroxide increase c-Myc and haeme-oxygenase 1 mRNA levels in rat pancreatic islets without activating NFκB

verfasst von: H. Elouil, A. K. Cardozo, D. L. Eizirik, J. C. Henquin, J. C. Jonas

Erschienen in: Diabetologia | Ausgabe 3/2005

Einloggen, um Zugang zu erhalten

Abstract

Aims/hypothesis

Hyperglycaemia and the pro-inflammatory cytokine IL-1β induce similar alterations of beta cell gene expression, including up-regulation of c-Myc and haeme-oxygenase 1. These effects of hyperglycaemia may result from nuclear factor-kappa B (NFκB) activation by oxidative stress. To test this hypothesis, we compared the effects of IL-1β, high glucose, and hydrogen peroxide, on NFκB DNA binding activity and target gene mRNA levels in cultured rat islets.

Methods

Rat islets were pre-cultured for 1 week in serum-free RPMI medium containing 10 mmol/l glucose, and further cultured in glucose concentrations of 5–30 mmol/l plus various test substances. Islet NFκB activity was measured by ELISA and gene mRNA expression was measured by RT-PCR.

Results

IL-1β consistently increased islet NFκB activity and c-Myc, haeme-oxygenase 1, inducible nitric oxide synthase (iNOS), Fas, and inhibitor of NFκB alpha (IκBα) mRNA levels. In comparison, 1- to 7-day culture in 30 mmol/l instead of 10 mmol/l glucose stimulated islet c-Myc and haeme-oxygenase 1 expression without affecting NFκB activity or iNOS and IκBα mRNA levels. Fas mRNA levels only increased after 1 week in 30 mmol/l glucose. Overnight exposure to hydrogen peroxide mimicked the effects of 30 mmol/l glucose on haeme-oxygenase 1 and c-Myc mRNA levels without activating NFκB. On the other hand, the antioxidant N-acetyl-l-cysteine inhibited the stimulation of haeme-oxygenase 1 and c-Myc expression by 30 mmol/l glucose and/or hydrogen peroxide.

Conclusions/interpretation

In contrast to IL-1β, high glucose and hydrogen peroxide do not activate NFκB in cultured rat islets. It is suggested that the stimulation of islet c-Myc and haeme-oxygenase 1 expression by 30 mmol/l glucose results from activation of a distinct, probably oxidative-stress-dependent signalling pathway.

Kahn SE (2003) The relative contributions of insulin resistance and β-cell dysfunction to the pathophysiology of type 2 diabetes. Diabetologia 46:3–19CrossRefPubMed

Buchanan TA (2003) Pancreatic β-cell loss and preservation in type 2 diabetes. Clin Ther 25(Suppl B):B32–B46CrossRef

Rahier J, Goebbels RM, Henquin JC (1983) Cellular composition of the human diabetic pancreas. Diabetologia 24:366–371CrossRef

Butler AE, Janson J, Bonner-Weir S, Ritzel R, Rizza RA, Butler PC (2003) β-cell deficit and increased β-cell apoptosis in humans with type 2 diabetes. Diabetes 52:102–110PubMed

Leahy JL (1996) Detrimental effects of chronic hyperglycemia on the pancreatic β-cell. In: LeRoith D, Taylor SI, Olefsky JM (eds) Diabetes mellitus, a fundamental and clinical text. Lippincott-Raven, Philadelphia, pp 103–113

Kaiser N, Leibowitz G, Nesher R (2003) Glucotoxicity and β-cell failure in type 2 diabetes mellitus. J Pediatr Endocrinol Metab 16:5–22PubMed

Eizirik DL, Mandrup-Poulsen T (2001) A choice of death—the signal-transduction of immune-mediated β-cell apoptosis. Diabetologia 44:2115–2133CrossRefPubMed

Tokuyama Y, Sturis J, DePaoli AM et al (1995) Evolution of β-cell dysfunction in the male Zucker diabetic fatty rat. Diabetes 44:1447–1457PubMed

Ling Z, Pipeleers DG (1996) Prolonged exposure of human β cells to elevated glucose levels results in sustained cellular activation leading to a loss of glucose regulation. J Clin Invest 98:2805–2812

10.

Ling Z, Kiekens R, Mahler T et al (1996) Effects of chronically elevated glucose levels on the functional properties of rat pancreatic β-cells. Diabetes 45:1774–1782

11.

Jonas JC, Sharma A, Hasenkamp W et al (1999) Chronic hyperglycemia triggers loss of pancreatic β cell differentiation in an animal model of diabetes. J Biol Chem 274:14112–14121CrossRefPubMed

12.

Laybutt DR, Kaneto H, Hasenkamp W et al (2002) Increased expression of antioxidant and antiapoptotic genes in islets that may contribute to β-cell survival during chronic hyperglycemia. Diabetes 51:413–423

13.

Piro S, Anello M, Di Pietro C et al (2002) Chronic exposure to free fatty acids or high glucose induces apoptosis in rat pancreatic islets: possible role of oxidative stress. Metabolism 51:1340–1347CrossRef

14.

Poitout V, Robertson RP (2002) Minireview: secondary β-cell failure in type 2 diabetes—a convergence of glucotoxicity and lipotoxicity. Endocrinology 143:339–342PubMed

15.

Kosaka K, Kuzuya T, Akanuma Y, Hagura R (1980) Increase in insulin response after treatment of overt maturity-onset diabetes is independent of the mode of treatment. Diabetologia 18:23–28CrossRef

16.

U.K. Prospective Diabetes Study Group (1995) U.K. prospective diabetes study 16. Overview of 6 years’ therapy of type II diabetes: a progressive disease. Diabetes 44:1249–1258

17.

Ling Z, Van de Casteele M, Eizirik DL, Pipeleers DG (2000) Interleukin-1β-induced alteration in a β-cell phenotype can reduce cellular sensitivity to conditions that cause necrosis but not to cytokine-induced apoptosis. Diabetes 49:340–345

18.

Cardozo AK, Kruhoffer M, Leeman R, Orntoft T, Eizirik DL (2001) Identification of novel cytokine-induced genes in pancreatic beta-cells by high-density oligonucleotide arrays. Diabetes 50:909–920PubMed

19.

Heimberg H, Heremans Y, Jobin C et al (2001) Inhibition of cytokine-induced NF-kappaB activation by adenovirus-mediated expression of a NF-kappaB super-repressor prevents beta-cell apoptosis. Diabetes 50:2219–2224PubMed

20.

Cardozo AK, Heimberg H, Heremans Y et al (2001) A comprehensive analysis of cytokine-induced and nuclear factor-κB-dependent genes in primary rat pancreatic β-cells. J Biol Chem 276:48879–48886CrossRefPubMed

21.

Pelengaris S, Khan M, Evan GI (2002) Suppression of Myc-induced apoptosis in β cells exposes multiple oncogenic properties of Myc and triggers carcinogenic progression. Cell 109:321–334CrossRef

22.

Laybutt DR, Weir GC, Kaneto H et al (2002) Overexpression of c-Myc in β-cells of transgenic mice causes proliferation and apoptosis, downregulation of insulin gene expression, and diabetes. Diabetes 51:1793–1804PubMed

23.

Van de Casteele M, Kefas BA, Cai Y et al (2003) Prolonged culture in low glucose induces apoptosis of rat pancreatic β-cells through induction of c-myc. Biochem Biophys Res Commun 312:937–944CrossRef

24.

Ye J, Laychock SG (1998) A protective role for heme oxygenase expression in pancreatic islets exposed to interleukin-1β. Endocrinology 139:4155–4163CrossRef

25.

Pileggi A, Molano RD, Berney T et al (2001) Heme oxygenase-1 induction in islet cells results in protection from apoptosis and improved in vivo function after transplantation. Diabetes 50:1983–1991

26.

Tobiasch E, Gunther L, Bach FH (2001) Heme oxygenase-1 protects pancreatic β cells from apoptosis caused by various stimuli. J Investig Med 49:566–571

27.

Jonas JC, Laybutt DR, Steil GM et al (2001) High glucose stimulates early response gene c-Myc expression in rat pancreatic β cells. J Biol Chem 276:35375–35381CrossRef

28.

Jonas JC, Guiot Y, Rahier J, Henquin JC (2003) Haeme-oxygenase 1 expression in rat pancreatic β-cells is stimulated by supraphysiological glucose concentrations and by cyclic AMP. Diabetologia 46:1234–1244CrossRef

29.

Efanova IB, Zaitsev SV, Zhivotovsky B et al (1998) Glucose and tolbutamide induce apoptosis in pancreatic β-cells—a process dependent on intracellular Ca²⁺ concentration. J Biol Chem 273:33501–33507CrossRefPubMed

30.

Kefas BA, Heimberg H, Vaulont S et al (2003) AICA-riboside induces apoptosis of pancreatic β cells through stimulation of AMP-activated protein kinase. Diabetologia 46:250–254

31.

Matsuoka T, Kajimoto Y, Watada H et al (1997) Glycation-dependent, reactive oxygen species-mediated suppression of the insulin gene promoter activity in HIT cells. J Clin Invest 99:144–150

32.

Kaneto H, Kajimoto Y, Miyagawa J et al (1999) Beneficial effects of antioxidants in diabetes: possible protection of pancreatic β-cells against glucose toxicity. Diabetes 48:2398–2406PubMed

33.

Tanaka Y, Tran PO, Harmon J, Robertson RP (2002) A role for glutathione peroxidase in protecting pancreatic β cells against oxidative stress in a model of glucose toxicity. Proc Natl Acad Sci U S A 99:12363–12368CrossRef

34.

Robertson RP, Harmon J, Tran PO, Tanaka Y, Takahashi H (2003) Glucose toxicity in β-cells: type 2 diabetes, good radicals gone bad, and the glutathione connection. Diabetes 52:581–587PubMed

35.

Maedler K, Sergeev P, Ris F et al (2002) Glucose-induced β cell production of IL-1β contributes to glucotoxicity in human pancreatic islets. J Clin Invest 110:851–860CrossRefPubMed

36.

Darville MI, Ho YS, Eizirik DL (2000) NF-kappaB is required for cytokine-induced manganese superoxide dismutase expression in insulin-producing cells. Endocrinology 141:153–162CrossRef

37.

Bustin SA (2000) Absolute quantification of mRNA using real-time reverse transcription polymerase chain reaction assays. J Mol Endocrinol 25:169–193PubMed

38.

Ririe KM, Rasmussen RP, Wittwer CT (1997) Product differentiation by analysis of DNA melting curves during the polymerase chain reaction. Anal Biochem 245:154–160CrossRefPubMed

39.

Heding LG (1972) Determination of total serum insulin (IRI) in insulin-treated diabetic patients. Diabetologia 8:260–266

40.

Khaldi MZ, Guiot Y, Gilon P, Henquin JC, Jonas JC (2004) Increased glucose sensitivity of both triggering and amplifying pathways of insulin secretion in rat islets cultured for one week in high glucose. Am J Physiol Endocrinol Metab 287:E207–E217CrossRef

41.

Darville MI, Eizirik DL (2001) Cytokine induction of Fas gene expression in insulin-producing cells requires the transcription factors NF-kappaB and C/EBP. Diabetes 50:1741–1748PubMed

42.

Kutlu B, Darville MI, Cardozo AK, Eizirik DL (2003) Molecular regulation of monocyte chemoattractant protein-1 expression in pancreatic β-cells. Diabetes 52:348–355

43.

Kharroubi I, Ladriere L, Cardozo AK, Dogusan Z, Cnop M, Eizirik DL (2004) Free fatty acids and cytokines induce pancreatic beta-cell apoptosis by different mechanisms: role of NF-kappa B and endoplasmic reticulum stress. Endocrinology 145:5087–5096CrossRef

44.

Bowie A, O’Neill LA (2000) Oxidative stress and nuclear factor-kappaB activation: a reassessment of the evidence in the light of recent discoveries. Biochem Pharmacol 59:13–23CrossRef

45.

Kaneto H, Xu G, Fujii N, Kim S, Bonner-Weir S, Weir GC (2002) Involvement of c-Jun N-terminal kinase in oxidative stress-mediated suppression of insulin gene expression. J Biol Chem 277:30010–30018PubMed

46.

Tacchini L, Fusar-Poli D, Bernelli-Zazzera A (2002) Activation of transcription factors by drugs inducing oxidative stress in rat liver. Biochem Pharmacol 63:139–148CrossRef

47.

Kaneto H, Suzuma K, Sharma A, Bonner-Weir S, King GL, Weir GC (2002) Involvement of protein kinase C β2 in c-myc induction by high glucose in pancreatic β-cells. J Biol Chem 277:3680–3685CrossRef

48.

Burns CJ, Squires PE, Persaud SJ (2000) Signaling through the p38 and p42/44 mitogen-activated families of protein kinases in pancreatic beta-cell proliferation. Biochem Biophys Res Commun 268:541–546CrossRef

49.

Tanaka Y, Gleason CE, Tran PO, Harmon JS, Robertson RP (1999) Prevention of glucose toxicity in HIT-T15 cells and Zucker diabetic fatty rats by antioxidants. Proc Natl Acad Sci U S A 96:10857–10862CrossRef

50.

Wu L, Nicholson W, Knobel SM et al (2004) Oxidative stress is a mediator of glucose toxicity in insulin-secreting pancreatic islet cell lines. J Biol Chem 279:12126–12134CrossRef

51.

Rasilainen S, Nieminen JM, Levonen AL, Otonkoski T, Lapatto R (2002) Dose-dependent cysteine-mediated protection of insulin-producing cells from damage by hydrogen peroxide. Biochem Pharmacol 63:1297–1304CrossRef

52.

Donath MY, Storling J, Maedler K, Mandrup-Poulsen T (2003) Inflammatory mediators and islet β-cell failure: a link between type 1 and type 2 diabetes. J Mol Med 81:455–470CrossRef

53.

Liu D, Cardozo AK, Darville MI, Eizirik DL (2002) Double-stranded RNA cooperates with interferon-gamma and IL-1β to induce both chemokine expression and nuclear factor-kappa B-dependent apoptosis in pancreatic β-cells: potential mechanisms for viral-induced insulitis and beta-cell death in type 1 diabetes mellitus. Endocrinology 143:1225–1234CrossRef

54.

Lefebvre VH, Otonkoski T, Ustinov J, Huotari MA, Pipeleers DG, Bouwens L (1998) Culture of adult human islet preparations with hepatocyte growth factor and 804G matrix is mitogenic for duct cells but not for β-cells. Diabetes 47:134–137

55.

Nishikawa T, Edelstein D, Du XL et al (2000) Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature 404:787–790CrossRefPubMed

56.

Bierhaus A, Schiekofer S, Schwaninger M et al (2001) Diabetes-associated sustained activation of the transcription factor nuclear factor-kappaB. Diabetes 50:2792–2808PubMed

57.

Evans JL, Goldfine ID, Maddux BA, Grodsky GM (2003) Are oxidative stress-activated signaling pathways mediators of insulin resistance and β-cell dysfunction? Diabetes 52:1–8

58.

Colson A, Willems B, Thissen JP (2003) Inhibition of TNF-α production by pentoxifylline does not prevent endotoxin-induced decrease in serum IGF-I. J Endocrinol 178:101–109PubMed

Titel: High glucose and hydrogen peroxide increase c-Myc and haeme-oxygenase 1 mRNA levels in rat pancreatic islets without activating NFκB
verfasst von: H. Elouil
A. K. Cardozo
D. L. Eizirik
J. C. Henquin
J. C. Jonas
Publikationsdatum: 01.03.2005
Verlag: Springer-Verlag
Erschienen in: Diabetologia / Ausgabe 3/2005
Print ISSN: 0012-186X
Elektronische ISSN: 1432-0428
DOI: https://doi.org/10.1007/s00125-004-1664-4

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

25.04.2024 | Hypotonie | Nachrichten

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

High glucose and hydrogen peroxide increase c-Myc and haeme-oxygenase 1 mRNA levels in rat pancreatic islets without activating NFκB

Abstract

Aims/hypothesis

Methods

Results

Conclusions/interpretation

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Update Innere Medizin

Springer Medizin

Abstract

Aims/hypothesis

Methods

Results

Conclusions/interpretation

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2005

A role for heterotrimeric GTP-binding proteins and ERK1/2 in insulin-mediated, nitric-oxide-dependent, cyclic GMP production in human umbilical vein endothelial cells

Activation of 12-lipoxygenase in proinflammatory cytokine-mediated beta cell toxicity

Potential involvement of adipocyte insulin resistance in obesity-associated up-regulation of adipocyte lysophospholipase D/autotaxin expression

The mitochondrial rhomboid protease PSARL is a new candidate gene for type 2 diabetes

Effect of common polymorphisms in the HNF4α promoter on susceptibility to type 2 diabetes in the French Caucasian population

The common T60N polymorphism of the lymphotoxin-α gene is associated with type 2 diabetes and other phenotypes of the metabolic syndrome

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Update Innere Medizin